{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:29:22Z","timestamp":1787203762320,"version":"build-2736575974"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2019.00718","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T03:46:23Z","timestamp":1555040783000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Potent Inhibition of Zika Virus Replication by Aurintricarboxylic Acid"],"prefix":"10.3389","volume":"10","author":[{"given":"Jun-Gyu","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gin\u00e9s","family":"\u00c1vila-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferralita","family":"Madere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Hilimire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitor","family":"Nogales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Almaz\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mart\u00ednez-Sobrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys.","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.15585\/mmwr.mm6511e1","article-title":"Travel-associated zika virus disease cases among u.s. residents\u2013united states, january 2015-february 2016.","volume":"65","author":"Armstrong","year":"2016","journal-title":"MMWR"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/v10110597","article-title":"Reverse genetic approaches for the generation of recombinant zika virus.","volume":"10","author":"Avila-Perez","year":"2018","journal-title":"Viruses"},{"key":"B4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0006-291X(86)90877-6","article-title":"Aurintricarboxylic acid and evans blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III\/lymphadenopathy-associated virus.","volume":"136","author":"Balzarini","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of zika virus pathogenesis by preexisting antiflavivirus immunity.","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A screen of FDA-approved drugs for inhibitors of zika virus infection.","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0006-2952(94)00465-X","article-title":"Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.","volume":"49","author":"Benchokroun","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"B8","first-page":"191","article-title":"Aurintricarboxylic acid is a nonspecific enzyme inhibitor.","volume":"12","author":"Bina-Stein","year":"1976","journal-title":"Mol. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits zika virus infection.","volume":"137","author":"Bullard-Feibelman","year":"2017","journal-title":"Antiviral Res."},{"key":"B10","first-page":"853","article-title":"Inhibition of topoisomerase II by aurintricarboxylic acid: implications for mechanisms of apoptosis.","volume":"14","author":"Catchpoole","year":"1994","journal-title":"Anticancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.bjp.0704955","article-title":"Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid.","volume":"137","author":"Chen","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3851\/IMP1286","article-title":"Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor.","volume":"20","author":"Chen","year":"2009","journal-title":"Antivir. Chem. Chemother."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005528","article-title":"Transmission of Zika virus through breast milk and other breastfeeding-related bodily-fluids: a systematic review.","volume":"11","author":"Colt","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1517\/14728214.10.2.241","article-title":"Emerging anti-HIV drugs.","volume":"10","author":"De Clercq","year":"2005","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27224-4","article-title":"The antiviral drug arbidol inhibits Zika virus.","volume":"8","author":"Fink","year":"2018","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.virol.2016.03.006","article-title":"The South Pacific epidemic strain of Zika virus replicates efficiently in human epithelial A549 cells leading to IFN-beta production and apoptosis induction.","volume":"493","author":"Frumence","year":"2016","journal-title":"Virology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-017-0761-1","article-title":"Inhibitors compounds of the flavivirus replication process.","volume":"14","author":"Garcia","year":"2017","journal-title":"Virol. J."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/v10040184","article-title":"Arbidol (Umifenovir): a broad-spectrum antiviral drug that inhibits medically important arthropod-borne flaviviruses.","volume":"10","author":"Haviernik","year":"2018","journal-title":"Viruses"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.bbrc.2004.06.076","article-title":"Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid.","volume":"320","author":"He","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0028-3908(99)00245-2","article-title":"Aurintricarboxylic acid promotes survival and regeneration of axotomised retinal ganglion cells in vivo.","volume":"39","author":"Heiduschka","year":"2000","journal-title":"Neuropharmacology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/srep34793","article-title":"Zika virus infection during the period of maximal brain growth causes microcephaly and corticospinal neuron apoptosis in wild type mice.","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/jac\/dkp502","article-title":"Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid.","volume":"65","author":"Hung","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.antiviral.2008.10.006","article-title":"Aurintricarboxylic acid inhibits influenza virus neuraminidase.","volume":"81","author":"Hung","year":"2009","journal-title":"Antiviral Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/jac\/dkn303","article-title":"In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum.","volume":"62","author":"Klein","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.antiviral.2016.12.022","article-title":"Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism.","volume":"139","author":"Kuivanen","year":"2017","journal-title":"Antiviral Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil.","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1128\/JVI.00252-16","article-title":"Zika virus: new clinical syndromes and its emergence in the western hemisphere.","volume":"90","author":"Lazear","year":"2016","journal-title":"J. Virol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8160","article-title":"Assessing the global threat from Zika virus.","volume":"353","author":"Lessler","year":"2016","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","first-page":"41734","DOI":"10.1074\/jbc.M307152200","article-title":"Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plague.","volume":"278","author":"Liang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/v10100547","article-title":"An alanine-to-valine substitution in the residue 175 of zika virus NS2A protein affects viral rna synthesis and attenuates the virus in vivo.","volume":"10","author":"Marquez-Jurado","year":"2018","journal-title":"Viruses"},{"key":"B31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2009.03.001","article-title":"Flaviviral methyltransferase\/RNA interaction: structural basis for enzyme inhibition.","volume":"83","author":"Milani","year":"2009","journal-title":"Antiviral Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/j.1365-2567.1996.510589.x","article-title":"HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid.","volume":"87","author":"Mitra","year":"1996","journal-title":"Immunology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"8607","DOI":"10.1093\/nar\/gks623","article-title":"Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays.","volume":"40","author":"Mukherjee","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1128\/JVI.02531-06","article-title":"Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication by targeting both cellular and viral factors.","volume":"81","author":"Myskiw","year":"2007","journal-title":"J. Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1055\/s-0036-1592071","article-title":"Pathogenesis and molecular mechanisms of zika virus.","volume":"34","author":"Nayak","year":"2016","journal-title":"Semin. Reprod. Med."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/v11010029","article-title":"A \u2019furry-tale\u2019 of zika virus infection: what have we learned from animal models?","volume":"11","author":"Nazerai","year":"2019","journal-title":"Viruses"},{"key":"B37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.virol.2014.12.006","article-title":"Replication-competent influenza a viruses expressing a red fluorescent protein.","volume":"476","author":"Nogales","year":"2015","journal-title":"Virology"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.9.20720","article-title":"Zika virus infection complicated by guillain-barre syndrome\u2013case report, french polynesia, december 2013.","volume":"19","author":"Oehler","year":"2014","journal-title":"Euro Surveill."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S906","DOI":"10.1093\/infdis\/jix513","article-title":"Humoral immune responses against zika virus infection and the importance of preexisting flavivirus immunity.","volume":"216","author":"Priyamvada","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/jmv.24563","article-title":"Zika virus: an update on epidemiology, pathology, molecular biology, and animal model.","volume":"88","author":"Ramos da Silva","year":"2016","journal-title":"J. Med. Virol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.03.016","article-title":"Modified mRNA vaccines protect against zika virus infection.","volume":"169","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"B42","first-page":"S93","article-title":"The zika virus: an association to guillain-barre syndrome in the united states - a case report.","volume":"37","author":"Rivera-Concepcion","year":"2018","journal-title":"P. R. Health Sci. J."},{"key":"B43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1471-4159.1993.tb03583.x","article-title":"Aurintricarboxylic acid protects hippocampal neurons from NMDA- and ischemia-induced toxicity in vivo.","volume":"61","author":"Roberts-Lewis","year":"1993","journal-title":"J. Neurochem."},{"key":"B44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1074\/jbc.273.1.28","article-title":"Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid.","volume":"273","author":"Rui","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1021\/bi4006495","article-title":"Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP.","volume":"52","author":"Shadrick","year":"2013","journal-title":"Biochemistry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nm.4322","article-title":"A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models.","volume":"23","author":"Shan","year":"2017","journal-title":"Nat. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3851\/IMP1480","article-title":"Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice.","volume":"20","author":"Smee","year":"2010","journal-title":"Antivir. Chem. Chemother."},{"key":"B48","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.81.3.1106","article-title":"Aurintricarboxylic acid in a canine model of coronary artery thrombosis.","volume":"81","author":"Strony","year":"1990","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.stem.2016.02.016","article-title":"Zika virus infects human cortical neural progenitors and attenuates their growth.","volume":"18","author":"Tang","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006258","article-title":"A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses.","volume":"13","author":"Tripathi","year":"2017","journal-title":"PLoS Pathog."},{"key":"B51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","article-title":"Zika virus: History, emergence, biology, and prospects for control.","volume":"130","author":"Weaver","year":"2016","journal-title":"Antiviral Res."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-018-0034-1","article-title":"Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry.","volume":"4","author":"Yang","year":"2018","journal-title":"Cell Discov"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.00718\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T03:46:27Z","timestamp":1555040787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.00718\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":52,"alternative-id":["10.3389\/fmicb.2019.00718"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2019.00718","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"article-number":"718"}}